Animal studies support that theory. GLP-1 drugs reduce inflammation in the brain and interfere with reward pathways linked to ...

Journavx is the first truly new painkiller approved by the Food and Drug Administration in more than 20 years. But the drug is expensive, and many people can't get it yet.

The agency first declared a shortage of semaglutide, the main ingredient used to make Ozempic and Wegovy, in 2022.

Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes management.

Discover the ins and outs of the MSI Z170A Gaming M5 BIOS in this detailed overview. Whether you're a seasoned gamer or a ...

A NEW weight loss jab that only needs to be taken once monthly leads to “substantial weight loss”, according to early trials. Drugs like Wegovy and Mounjaro – or diabetes jab Ozem… ...

A new oral drug may be able to treat type 2 diabetes and obesity without impacting muscle mass as an alternative to GLP-1 drugs such as Ozempic, the results of a phase 1 clinical trial suggest.

The UK's health regulator is investigating Ozempic and Mounjaro after linking the drugs to hundreds of severe illnesses and deaths.

Everyone’s Talking About Ozempic, But What Does It Mean For Indian Women's Metabolism? With PCOS, insulin resistance, and early diabetes risk, Indian women face unique metabolic challenges.

Other protein-based medicines include GLP-1 weight-loss drugs like Ozempic and Wegovy, and antibody treatments like Herceptin for cancer. How can AI develop new medicines like these? If you design ...